Eledon Pharmaceuticals
ELDN
ELDN
16 hedge funds and large institutions have $27.2M invested in Eledon Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$600K | |
| 2 | +$282K | |
| 3 | +$240K | |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$136K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$76K |
Top Sellers
| 1 | -$389K | |
| 2 | -$67K | |
| 3 | -$13K | |
| 4 |
D.E. Shaw & Co
New York
|
-$6.58K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$1.5K |